Sunshine Biopharma (SBFM) Share-based Compensation (2010 - 2024)

Sunshine Biopharma (SBFM) reported Share-based Compensation of $12000.0 for Q1 2024, down 98.69% quarter-over-quarter from $918000.0 in Q1 2021.

Sunshine Biopharma (SBFM) Share-based Compensation (2010 - 2024) Analysis & Trends

Sunshine Biopharma has reported Share-based Compensation for 12 years, with the latest figure at $12000.0 in Q1 2024.

For the quarter ending Q1 2024, Share-based Compensation changed N/A year-over-year to $12000.0; the trailing twelve-month figure through Dec 2024 stood at $12000.0 (changed N/A YoY), and the FY2024 full-year result was $12000.0, changed N/A from the prior year.
Share-based Compensation for Q1 2024 stood at $12000.0, down from $918000.0 in the prior quarter.
The five-year high for Share-based Compensation was $918000.0 in Q1 2021, with the low at $12000.0 in Q1 2024.
Historically, Share-based Compensation has averaged $326666.7 across 3 years, with a median of $50000.0 in 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Share-based Compensation (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	43.00 Mn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	25.00 Mn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	33.90 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-395,114.54
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	57.20 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	21.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	36.33 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	36.86 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	16.04 Mn
10	Sunshine Biopharma	10.94 Mn	4.03 Mn	2.18 Mn	-

Download Data